プロモーションスケジュール Aladdin Healthcare Technologies SE
詳細なスケジュール
簡易グラフ
会社について
Aladdin Healthcare Technologies SE, through its subsidiary, Aladdin Healthcare Technologies Ltd, develops software solutions for the storage and management of health information using blockchain technology. The company provides Artificial Intelligence assisted Drug Discovery platform to identify various small molecule drug compounds with multiple age-related diseases, including Alzheimer's, Parkinson's, and SARS-CoV-2; PharmaKG, a biomedical knowledge graph; and Disease Diagnosis and Risk Assessment Platform. The company was founded in 2014 and is based in Berlin, Germany.
| 1日あたりの価格変動: |
+0% (0.014) |
| 週ごとの価格変動: |
+0% (0.014) |
| 月ごとの料金変更: |
+0% (0.014) |
| 3ヶ月間の価格変動: |
+0% (0.014) |
| 半年間の価格変動: |
+0% (0.014) |
| 年間の価格変動: |
+0% (0.014) |
| 3年間の価格推移: |
-95.41% (0.305) |
| 5年間の価格推移: |
+0% (0.014) |
| 10年間の価格推移: |
+0% (0.014) |
| 年初からの価格変動: |
+0% (0.014) |
|
|
過小評価
| 名前 |
意味 |
学年 |
| P/S |
0 |
0 |
| P/BV |
0 |
0 |
| P/E |
0 |
0 |
| EV/EBITDA |
0 |
0 |
| 合計: |
|
2.5 |
|
効率
| 名前 |
意味 |
学年 |
| ROA, % |
0 |
0 |
| ROE, % |
0 |
0 |
| 合計: |
|
0 |
|
|
|
配当金
| 名前 |
意味 |
学年 |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| 合計: |
|
0 |
|
義務
| 名前 |
意味 |
学年 |
| Debt/EBITDA |
0 |
10 |
| 合計: |
|
10 |
|
成長の衝動
| 名前 |
意味 |
学年 |
| 収益性 Revenue, % |
0 |
0 |
| 収益性 Ebitda, % |
1264.44 |
10 |
| 収益性 EPS, % |
-108.92 |
0 |
| 合計: |
|
6 |
|
| スーパーバイザー |
役職 |
支払い |
生年 |
| Mr. Wade Menpes-Smith |
Chairman of the Board, CEO & MD |
|
|
| Mr. Bimal Shah |
Deputy Chairman & COO |
|
|
| Mr. Hamish Badenoch |
CFO & Director |
|
|
| Prof. David C. Rubinsztein |
Member of Drug Discovery Advisory Board & Chief Scientific Advisor |
|
|
| Mr. Paul Sitoh |
Head of Blockchain Technology |
|
|
